董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Yuval Yanai | 男 | External Director | 65 | 未披露 | 2.02 | 2017-12-31 |
| Jonathan Adereth | 男 | Chairman of the Board of Director | 71 | 38.68万美元 | 12.04 | 2017-12-31 |
| Ori Hadomi | 男 | Director and Chief Executive Officer | 50 | 146.52万美元 | 37.52 | 2017-12-31 |
| Gil Bianco | 男 | External Director | 66 | 未披露 | 2.02 | 2017-12-31 |
| Sarit Soccary Ben Yochanan | 女 | Director | 45 | 未披露 | 0.66 | 2017-12-31 |
| Michael Berman | 男 | Director | 60 | 未披露 | 2.62 | 2017-12-31 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Inbal Azar | 女 | Vice President, Quality Assurance & Regulatory Affairs | 48 | 未披露 | 未持股 | 2017-12-31 |
| Joshua Belkar | 男 | Vice President, Operation & Global Service | 49 | 未披露 | 未持股 | 2017-12-31 |
| Doron Tavlin | 男 | Vice President, Business Development | 66 | 未披露 | 未持股 | 2017-12-31 |
| Oren Zarchin | -- | Vice President, Product Development | 41 | 未披露 | 未持股 | 2017-12-31 |
| Ori Hadomi | 男 | Director and Chief Executive Officer | 50 | 146.52万美元 | 37.52 | 2017-12-31 |
| Sharon Levita | 女 | Chief Financial Officer, Corporate Secretary, Vice President Business Operations | 50 | 58.06万美元 | 9.20 | 2017-12-31 |
| Moshe Shoham | 男 | Chief Technology Officer | 66 | 未披露 | 未持股 | 2017-12-31 |
| Eliyahu Zehavi | 男 | Executive Vice President, Advanced Technologies | 62 | 57.91万美元 | 6.21 | 2017-12-31 |
| Doron Dinstein | 男 | Chief Medical Officer | 47 | 36.16万美元 | 5.46 | 2017-12-31 |
| Christopher Prentice | 男 | Chief Executive Officer, Mazor Robotics Inc. & Chief Commercial Officer | 47 | 81.24万美元 | 20.34 | 2017-12-31 |
董事简历
中英对照 | 中文 | 英文- Yuval Yanai
-
Yuval Yanai从2005年9月到2014年3月，Yanai先生担任基文影像公司（Given Imaging Ltd.）的高级副总裁兼首席财务官。从2000年10月到2005年8月，他担任库尔工业公司（Koor Industries Ltd.）的高级副总裁兼首席财务官，其为以色列最大的控股公司之一。在这之前，从1998年4月到2000年9月，他担任NICE Systems Ltd.的副总裁兼首席财务官，这是一家以色列的交互洞察（Insight from Interactions）系统的全球供应商，从1991年到1998年4月，他担任爱尔新特公司（Elscint Ltd.）的财务部副总裁兼首席财务官，这是一家致力于医疗成像设备制造的前以色列公司，其被该行业规模更大的公司收购。他于1985年加入Elscint，并担任公司财务总管与公司财务主管至1991年。在这之前，Yanai先生担任Citycon Oj、Starplast Industries Ltd.、 Adama Ltd.（以前该公司叫Makteshim-Agan Industries Ltd.）、 ECI Telecom Ltd.、Equity One, Inc.、 BVR Systems Ltd.、Tadiran Communication Ltd.、 The Elisra Group与Telrad Networks Ltd.。Yanai先生在特拉维夫大学（Tel-Aviv University）获得会计学与经济学理学学士学位。
Yuval Yanai served as Senior Vice President and Chief Financial Officer of Given Imaging Ltd. from September 2005 through March 2014. From October 2000 through August 2005 Mr. Yanai served as Senior Vice President and Chief Financial Officer of Koor Industries Ltd. Prior to that, from April 1998 to September 2000 Mr. Yanai served as Vice President and Chief Financial Officer of NICE Systems Ltd., an Israeli global provider of Insight from Interactions, and, from 1991 to April 1998 he served as the Vice President, Finance and Chief Financial Officer of Elscint Ltd., a former Israeli company engaged in the developing and manufacturing of medical imaging devices. Mr. Yanai joined Elscint in 1985 and served as Corporate Controller and Corporate Treasurer through 1991. Mr. Yanai also serves as an external director within the meaning of the Israeli Companies Law of Hadassah Medical Organization, and serves as the Chairman of its finance and compensation committees and as a member of its tenders and donation committee. Mr. Yanai also serves as an external director within the meaning of the Israeli Companies Law of S&P Global Maalot. Mr. Yanai also serves as an external director (within the meaning of the Israeli Companies Law) of Clal Biotechnology Industries and serves as the Chairman of its audit and financial reporting committees, and as a member of its compensation committee. Mr. Yanai also serves as a member of the board of directors of Nobio Ltd. and BRH Medical Ltd. Previously, Mr. Yanai served as an external director (within the meaning of the Israeli Companies Law) of Mazor Robotics Ltd. and Medical Compression Systems Ltd. and as a director of Medigus Ltd. Mr. Yanai also served as a director of Macrocure Ltd., Citycon Oj, Starplast Industries Ltd., Adama Ltd. (formerly Makteshim-Agan Industries Ltd.), ECI Telecom Ltd., Equity One, Inc., BVR Systems Ltd., Tadiran Communication Ltd., The Elisra Group, Telrad Networks Ltd. and Medical Compression Systems (D.B.N) Ltd. Mr. Yanai holds a B.Sc. degree in Accounting and Economics from Tel-Aviv University. - Yuval Yanai从2005年9月到2014年3月，Yanai先生担任基文影像公司（Given Imaging Ltd.）的高级副总裁兼首席财务官。从2000年10月到2005年8月，他担任库尔工业公司（Koor Industries Ltd.）的高级副总裁兼首席财务官，其为以色列最大的控股公司之一。在这之前，从1998年4月到2000年9月，他担任NICE Systems Ltd.的副总裁兼首席财务官，这是一家以色列的交互洞察（Insight from Interactions）系统的全球供应商，从1991年到1998年4月，他担任爱尔新特公司（Elscint Ltd.）的财务部副总裁兼首席财务官，这是一家致力于医疗成像设备制造的前以色列公司，其被该行业规模更大的公司收购。他于1985年加入Elscint，并担任公司财务总管与公司财务主管至1991年。在这之前，Yanai先生担任Citycon Oj、Starplast Industries Ltd.、 Adama Ltd.（以前该公司叫Makteshim-Agan Industries Ltd.）、 ECI Telecom Ltd.、Equity One, Inc.、 BVR Systems Ltd.、Tadiran Communication Ltd.、 The Elisra Group与Telrad Networks Ltd.。Yanai先生在特拉维夫大学（Tel-Aviv University）获得会计学与经济学理学学士学位。
- Yuval Yanai served as Senior Vice President and Chief Financial Officer of Given Imaging Ltd. from September 2005 through March 2014. From October 2000 through August 2005 Mr. Yanai served as Senior Vice President and Chief Financial Officer of Koor Industries Ltd. Prior to that, from April 1998 to September 2000 Mr. Yanai served as Vice President and Chief Financial Officer of NICE Systems Ltd., an Israeli global provider of Insight from Interactions, and, from 1991 to April 1998 he served as the Vice President, Finance and Chief Financial Officer of Elscint Ltd., a former Israeli company engaged in the developing and manufacturing of medical imaging devices. Mr. Yanai joined Elscint in 1985 and served as Corporate Controller and Corporate Treasurer through 1991. Mr. Yanai also serves as an external director within the meaning of the Israeli Companies Law of Hadassah Medical Organization, and serves as the Chairman of its finance and compensation committees and as a member of its tenders and donation committee. Mr. Yanai also serves as an external director within the meaning of the Israeli Companies Law of S&P Global Maalot. Mr. Yanai also serves as an external director (within the meaning of the Israeli Companies Law) of Clal Biotechnology Industries and serves as the Chairman of its audit and financial reporting committees, and as a member of its compensation committee. Mr. Yanai also serves as a member of the board of directors of Nobio Ltd. and BRH Medical Ltd. Previously, Mr. Yanai served as an external director (within the meaning of the Israeli Companies Law) of Mazor Robotics Ltd. and Medical Compression Systems Ltd. and as a director of Medigus Ltd. Mr. Yanai also served as a director of Macrocure Ltd., Citycon Oj, Starplast Industries Ltd., Adama Ltd. (formerly Makteshim-Agan Industries Ltd.), ECI Telecom Ltd., Equity One, Inc., BVR Systems Ltd., Tadiran Communication Ltd., The Elisra Group, Telrad Networks Ltd. and Medical Compression Systems (D.B.N) Ltd. Mr. Yanai holds a B.Sc. degree in Accounting and Economics from Tel-Aviv University.
- Jonathan Adereth
-
Jonathan Adereth，从2007年12月起担任公司董事会主席。从2009年5月起，他在Medic Vision Imaging Solutions（一家以色列公司，主要从事在电脑断层扫描领域减少剂量的相关工作）担任董事长。从2004年10月起，他在UltraSPECT（一家以色列公司，主要从事在核医学领域减少剂量的相关工作）担任董事会成员。从2012年2月起，他在UCCare （一家以色列的前列腺癌诊断及治疗公司）担任董事，后来担任董事长。从1994年至1998年，他在Elscint（NYSE： ELT）（一家全球性的CT、 MRI 和 NM 系统的开发商和制造商）担任总裁兼首席执行官。他持有Technion-Israel Institute of Technology的物理学学士学位。
Jonathan Adereth has been serving as the chairman of our board of directors since December 2007. Since May 2009 Mr. Adereth has been serving as the chairman of Medic Vision Imaging Solutions Ltd., an Israeli company in the field of resolution recovery and dose reduction in Computed Tomography. Since October 2004 Mr. Adereth has been serving as a board member of UltraSPECT Ltd., an Israeli company in the field of resolution recovery and dose reduction in Nuclear Medicine. From 1994 to 1998 Mr. Adereth served as Chief Executive Officer of Elscint Ltd. NYSE: ELT, a global developer and manufacturer of Medical Imaging systems. Mr. Adereth holds a B.Sc. degree in Physics from the Technion - Israel Institute of Technology. - Jonathan Adereth，从2007年12月起担任公司董事会主席。从2009年5月起，他在Medic Vision Imaging Solutions（一家以色列公司，主要从事在电脑断层扫描领域减少剂量的相关工作）担任董事长。从2004年10月起，他在UltraSPECT（一家以色列公司，主要从事在核医学领域减少剂量的相关工作）担任董事会成员。从2012年2月起，他在UCCare （一家以色列的前列腺癌诊断及治疗公司）担任董事，后来担任董事长。从1994年至1998年，他在Elscint（NYSE： ELT）（一家全球性的CT、 MRI 和 NM 系统的开发商和制造商）担任总裁兼首席执行官。他持有Technion-Israel Institute of Technology的物理学学士学位。
- Jonathan Adereth has been serving as the chairman of our board of directors since December 2007. Since May 2009 Mr. Adereth has been serving as the chairman of Medic Vision Imaging Solutions Ltd., an Israeli company in the field of resolution recovery and dose reduction in Computed Tomography. Since October 2004 Mr. Adereth has been serving as a board member of UltraSPECT Ltd., an Israeli company in the field of resolution recovery and dose reduction in Nuclear Medicine. From 1994 to 1998 Mr. Adereth served as Chief Executive Officer of Elscint Ltd. NYSE: ELT, a global developer and manufacturer of Medical Imaging systems. Mr. Adereth holds a B.Sc. degree in Physics from the Technion - Israel Institute of Technology.
- Ori Hadomi
-
Ori Hadomi，从2003年1月起担任我们公司的首席执行官和董事会成员。在加入我们公司之前，他在Image Navigation（原DenX Medical Software Systems）担任首席财务官及业务发展副总裁。他在耶路撒冷的Hebrew University获得了化学学士学位及经济学辅修学位，以及工业化学与工商管理硕士学位。
Ori Hadomi has been serving as our Chief Executive Officer and a member of our board of directors since January 2003. Prior to joining us, Mr. Hadomi served as the chief financial officer and vice president of business development of Image Navigation Ltd. formerly known as DenX Medical Software Systems Ltd.. Mr. Hadomi holds a B.A. in chemistry with a minor in economics, as well as a M.Sc. in industrial chemistry and business administration from the Hebrew University, Jerusalem. - Ori Hadomi，从2003年1月起担任我们公司的首席执行官和董事会成员。在加入我们公司之前，他在Image Navigation（原DenX Medical Software Systems）担任首席财务官及业务发展副总裁。他在耶路撒冷的Hebrew University获得了化学学士学位及经济学辅修学位，以及工业化学与工商管理硕士学位。
- Ori Hadomi has been serving as our Chief Executive Officer and a member of our board of directors since January 2003. Prior to joining us, Mr. Hadomi served as the chief financial officer and vice president of business development of Image Navigation Ltd. formerly known as DenX Medical Software Systems Ltd.. Mr. Hadomi holds a B.A. in chemistry with a minor in economics, as well as a M.Sc. in industrial chemistry and business administration from the Hebrew University, Jerusalem.
- Gil Bianco
-
Gil Bianco，他自2007年一直担任外部董事。从2001年到2003年，他担任Agis Industries（一家药品制造商）的首席执行官，最主要的是参与了公司在特拉维夫证券交易所的上市及其全球扩张。他担任Fischer pharmaceuticals, IntekPharma, Clear Cut, Gil Bianco和Turquoise GEI 的董事。在过去的五年里，他还担任过Healor, Solgel Technologies, BioKansel, Top Spin, Kolbar, BioLineRx, DPharm, Optima和 Tel Aviv Stock Exchange的董事。他在Tel-Aviv University获得了经济学与会计学的学士学位。他是一名注册会计师。
Gil Bianco has served on our board of directors since April 2010. From November 2009 to November 2012 Mr. Bianco served as a director of D-Pharm Ltd., an Israeli public biopharmaceutical company, and from May 2007 to May 2010 Mr. Bianco served as a director of BioLineRx Ltd. Nasdaq: BLRX, a clinical-stage biopharmaceutical development company. From December 2003 to December 2009 Mr. Bianco served as an external director of the Tel Aviv Stock Exchange Ltd. Prior to that, from 2001 to 2003 Mr. Bianco served as chief executive officer of Agis Industries Ltd., a pharmaceutical manufacturer. Mr. Bianco previously served as an external director at Mazor Robotics Ltd. (Nasdaq: MZOR), a medical device company, from November 2007 until its acquisition in 2018. Mr. Bianco is also a director of several private companies in the fields of biotech and medical devices. Mr. Bianco holds a B.A. in economics and accounting from Tel-Aviv University in Tel-Aviv, Israel and is a certified public accountant in Israel. - Gil Bianco，他自2007年一直担任外部董事。从2001年到2003年，他担任Agis Industries（一家药品制造商）的首席执行官，最主要的是参与了公司在特拉维夫证券交易所的上市及其全球扩张。他担任Fischer pharmaceuticals, IntekPharma, Clear Cut, Gil Bianco和Turquoise GEI 的董事。在过去的五年里，他还担任过Healor, Solgel Technologies, BioKansel, Top Spin, Kolbar, BioLineRx, DPharm, Optima和 Tel Aviv Stock Exchange的董事。他在Tel-Aviv University获得了经济学与会计学的学士学位。他是一名注册会计师。
- Gil Bianco has served on our board of directors since April 2010. From November 2009 to November 2012 Mr. Bianco served as a director of D-Pharm Ltd., an Israeli public biopharmaceutical company, and from May 2007 to May 2010 Mr. Bianco served as a director of BioLineRx Ltd. Nasdaq: BLRX, a clinical-stage biopharmaceutical development company. From December 2003 to December 2009 Mr. Bianco served as an external director of the Tel Aviv Stock Exchange Ltd. Prior to that, from 2001 to 2003 Mr. Bianco served as chief executive officer of Agis Industries Ltd., a pharmaceutical manufacturer. Mr. Bianco previously served as an external director at Mazor Robotics Ltd. (Nasdaq: MZOR), a medical device company, from November 2007 until its acquisition in 2018. Mr. Bianco is also a director of several private companies in the fields of biotech and medical devices. Mr. Bianco holds a B.A. in economics and accounting from Tel-Aviv University in Tel-Aviv, Israel and is a certified public accountant in Israel.
- Sarit Soccary Ben Yochanan
-
Sarit Soccary Ben Yochanan，从2006年10月起担任董事。从2013年7月起，她在Syneron Medical（ NASDAQ： ELOS）担任战略与业务发展副总裁。到2013年7月，她一直在Gefen Biomed Investments（一家以色列上市公司）担任首席执行官。她还是Proteologics（一家以色列的上市生物技术公司）的董事。她还在几家技术与医疗保健领域的私人公司担任董事。她持有Tel Aviv University的经济学学士和硕士学位。
Sarit Soccary Ben Yochanan has been serving as a director since October 2006. Since July 2017 Mrs. Soccary has been serving as general manager for Syneron Medical Ltd. site in Israel. She previously served as the vice president of strategy and business development for Syneron Medical Ltd. From July 2013 until July 2017. Until July 2013 Mrs. Soccary had served as the chief executive officer of Gefen Biomed Investments Ltd., an Israeli public company. Mrs. Soccary also serves as a director of Lupert Ltd., IB Ventures Ltd. and as a member of the Ben Gurion University patent committee. Mrs. Soccary holds a B.A. and an M.A. in economics from Tel Aviv University. - Sarit Soccary Ben Yochanan，从2006年10月起担任董事。从2013年7月起，她在Syneron Medical（ NASDAQ： ELOS）担任战略与业务发展副总裁。到2013年7月，她一直在Gefen Biomed Investments（一家以色列上市公司）担任首席执行官。她还是Proteologics（一家以色列的上市生物技术公司）的董事。她还在几家技术与医疗保健领域的私人公司担任董事。她持有Tel Aviv University的经济学学士和硕士学位。
- Sarit Soccary Ben Yochanan has been serving as a director since October 2006. Since July 2017 Mrs. Soccary has been serving as general manager for Syneron Medical Ltd. site in Israel. She previously served as the vice president of strategy and business development for Syneron Medical Ltd. From July 2013 until July 2017. Until July 2013 Mrs. Soccary had served as the chief executive officer of Gefen Biomed Investments Ltd., an Israeli public company. Mrs. Soccary also serves as a director of Lupert Ltd., IB Ventures Ltd. and as a member of the Ben Gurion University patent committee. Mrs. Soccary holds a B.A. and an M.A. in economics from Tel Aviv University.
- Michael Berman
-
Michael Berman，自2013年2月7日起担任InspireMD, Inc.董事。他是一名医疗设备企业家，自2014年以来一直在高潜力开发和早期商业公司工作。从2005年到2012年，Berman先生是BridgePoint Medical, Inc.的联合创始人兼董事长，该公司开发了治疗冠状动脉和周围血管慢性全闭塞的技术，该公司已出售给Boston Scientific。2007年至2011年，他也是Lutonix, Inc.的董事会成员，当时该公司被出售给C.R. Bard, Inc.。2011年至2018年，他担任Rebiotix Inc.（开发C Diff结肠炎创新治疗的公司）的联合创始人兼董事。Rebiotix于2018年被出售给Ferring Pharmaceuticals。从2014年到2018年，Berman先生担任Mazor Robotics（脊柱机器人手术的先驱公司）的董事。Mazor于2018年被出售给美敦力。他曾担任（i）自2011年起担任Cardiosonic, Inc.的顾问，并自2012年起担任Cardiosonic, Inc.的董事，Cardiosonic, Inc.是一家开发通过肾去神经控制降低高血压系统的公司；（ii）自2005年起担任PharmaCentra, LLC的董事，该公司创建可定制的营销计划，帮助制药公司与医生和患者沟通；（iii）自2018年起担任STMedical的董事。（iv）自2019年起担任CardiacSense Inc（一家开发智能手表生命体征监视器的医疗设备公司）的董事，（v）自2017年起担任Owlytics Healthcare的董事，（vi）自2013年起担任ClearCut Inc.（一家开发用于肿瘤边缘评估的MRI系统的医疗设备公司）的董事，（vii）自2013年起担任PulmOne Ltd.的董事。（viii）自2019年起担任医疗设备公司QArt的董事，（ix）自2014年起担任RiverVest Ventures的风险合伙人。（x）自2017年起担任Truleaf Medical的董事；（xi）自2022年起担任Kedma Solar Ltd的董事。
Michael Berman,has served as Inspiremd, Inc. director since February 7, 2013. Mr. Berman is a medical device entrepreneur who has worked with high-potential development and early-stage commercial companies since 2014. From 2005 to 2012, Mr. Berman was a co-founder and the chairman of BridgePoint Medical, Inc., which developed technology to treat coronary and peripheral vascular chronic total occlusions and which was sold to Boston Scientific. Mr. Berman was also a member of the board of Lutonix, Inc. from 2007 until 2011, when the company was sold to C.R. Bard, Inc. From 2011 to 2018, Mr. Berman served as a co-founder and director of Rebiotix Inc., a company developing an innovative treatment for C Diff colitis. Rebiotix was sold to Ferring Pharmaceuticals in 2018. From 2014 till 2018 Mr. Berman served as a director of Mazor Robotics, a company pioneering Spinal Robotic Surgery. Mazor was sold to Medtronic in 2018. Mr. Berman has served (i) since 2011 as an advisor to, and since 2012 as a director of, Cardiosonic, Inc., a company developing a system for hypertension reduction via renal denervation, (ii) since 2005 as a director of PharmaCentra, LLC, which creates customizable marketing programs that help pharmaceutical companies communicate with physicians and patients, (iii) since 2018 as a Director of STMedical, a medical device company that has developed a temporary stent for the treatment of chronic sinusitis, (iv) since 2019 as a director of CardiacSense Inc, a medical device company that has developed a smart watch vital sign monitor, (v) since 2017 as a Director of Owlytics Healthcare, (vi) since 2013 as a Director of ClearCut Inc., a medical device company that has developed an MRI system for tumor margin assessment, (vii) since 2013 as a director of PulmOne Ltd., a medical device company developing an innovative Pulmonary Function Testing system, (viii) since 2019 as a director of QArt, a medical device company, (ix) since 2014 as a venture partner at RiverVest Ventures. (x) since 2017 as a Director of Truleaf Medical and (xi) since 2022 as a Director of Kedma Solar Ltd. - Michael Berman，自2013年2月7日起担任InspireMD, Inc.董事。他是一名医疗设备企业家，自2014年以来一直在高潜力开发和早期商业公司工作。从2005年到2012年，Berman先生是BridgePoint Medical, Inc.的联合创始人兼董事长，该公司开发了治疗冠状动脉和周围血管慢性全闭塞的技术，该公司已出售给Boston Scientific。2007年至2011年，他也是Lutonix, Inc.的董事会成员，当时该公司被出售给C.R. Bard, Inc.。2011年至2018年，他担任Rebiotix Inc.（开发C Diff结肠炎创新治疗的公司）的联合创始人兼董事。Rebiotix于2018年被出售给Ferring Pharmaceuticals。从2014年到2018年，Berman先生担任Mazor Robotics（脊柱机器人手术的先驱公司）的董事。Mazor于2018年被出售给美敦力。他曾担任（i）自2011年起担任Cardiosonic, Inc.的顾问，并自2012年起担任Cardiosonic, Inc.的董事，Cardiosonic, Inc.是一家开发通过肾去神经控制降低高血压系统的公司；（ii）自2005年起担任PharmaCentra, LLC的董事，该公司创建可定制的营销计划，帮助制药公司与医生和患者沟通；（iii）自2018年起担任STMedical的董事。（iv）自2019年起担任CardiacSense Inc（一家开发智能手表生命体征监视器的医疗设备公司）的董事，（v）自2017年起担任Owlytics Healthcare的董事，（vi）自2013年起担任ClearCut Inc.（一家开发用于肿瘤边缘评估的MRI系统的医疗设备公司）的董事，（vii）自2013年起担任PulmOne Ltd.的董事。（viii）自2019年起担任医疗设备公司QArt的董事，（ix）自2014年起担任RiverVest Ventures的风险合伙人。（x）自2017年起担任Truleaf Medical的董事；（xi）自2022年起担任Kedma Solar Ltd的董事。
- Michael Berman,has served as Inspiremd, Inc. director since February 7, 2013. Mr. Berman is a medical device entrepreneur who has worked with high-potential development and early-stage commercial companies since 2014. From 2005 to 2012, Mr. Berman was a co-founder and the chairman of BridgePoint Medical, Inc., which developed technology to treat coronary and peripheral vascular chronic total occlusions and which was sold to Boston Scientific. Mr. Berman was also a member of the board of Lutonix, Inc. from 2007 until 2011, when the company was sold to C.R. Bard, Inc. From 2011 to 2018, Mr. Berman served as a co-founder and director of Rebiotix Inc., a company developing an innovative treatment for C Diff colitis. Rebiotix was sold to Ferring Pharmaceuticals in 2018. From 2014 till 2018 Mr. Berman served as a director of Mazor Robotics, a company pioneering Spinal Robotic Surgery. Mazor was sold to Medtronic in 2018. Mr. Berman has served (i) since 2011 as an advisor to, and since 2012 as a director of, Cardiosonic, Inc., a company developing a system for hypertension reduction via renal denervation, (ii) since 2005 as a director of PharmaCentra, LLC, which creates customizable marketing programs that help pharmaceutical companies communicate with physicians and patients, (iii) since 2018 as a Director of STMedical, a medical device company that has developed a temporary stent for the treatment of chronic sinusitis, (iv) since 2019 as a director of CardiacSense Inc, a medical device company that has developed a smart watch vital sign monitor, (v) since 2017 as a Director of Owlytics Healthcare, (vi) since 2013 as a Director of ClearCut Inc., a medical device company that has developed an MRI system for tumor margin assessment, (vii) since 2013 as a director of PulmOne Ltd., a medical device company developing an innovative Pulmonary Function Testing system, (viii) since 2019 as a director of QArt, a medical device company, (ix) since 2014 as a venture partner at RiverVest Ventures. (x) since 2017 as a Director of Truleaf Medical and (xi) since 2022 as a Director of Kedma Solar Ltd.
高管简历
中英对照 | 中文 | 英文- Inbal Azar
Inbal Azar自2016年8月以来一直担任我们的Vice President，质量保证和法规事务。从2015年到2016年，Azar女士担任D.I.R.Technologies的质量和服务Vice President。从2007年到2014年，Azar女士担任通用电气梦百合的质量经理。Azar女士拥有工商管理硕士学位。食品工程和生物技术硕士学位。在质量保证和可靠性和工商管理硕士学位，都来自以色列理工学院。
Inbal Azar has been serving as our Vice President, Quality Assurance & Regulatory Affairs since August 2016. From 2015 to 2016 Mrs. Azar served as vice president of quality and service of D.I.R. Technologies. From 2007 to 2014 Mrs. Azar served as quality manager in General Electric Healthcare. Mrs. Azar holds a B.Sc. in Food Engineering and Bio-technology and M.Sc. in Quality Assurance and Reliability and an M.B.A., all from the Technion - Israel Institute of Technology.- Inbal Azar自2016年8月以来一直担任我们的Vice President，质量保证和法规事务。从2015年到2016年，Azar女士担任D.I.R.Technologies的质量和服务Vice President。从2007年到2014年，Azar女士担任通用电气梦百合的质量经理。Azar女士拥有工商管理硕士学位。食品工程和生物技术硕士学位。在质量保证和可靠性和工商管理硕士学位，都来自以色列理工学院。
- Inbal Azar has been serving as our Vice President, Quality Assurance & Regulatory Affairs since August 2016. From 2015 to 2016 Mrs. Azar served as vice president of quality and service of D.I.R. Technologies. From 2007 to 2014 Mrs. Azar served as quality manager in General Electric Healthcare. Mrs. Azar holds a B.Sc. in Food Engineering and Bio-technology and M.Sc. in Quality Assurance and Reliability and an M.B.A., all from the Technion - Israel Institute of Technology.
- Joshua Belkar
Joshua Belkar自2019年6月起担任运营Vice President。Belkar先生拥有超过20年的在全球医疗器械公司管理运营的经验，包括管理基于胶囊的产品的大批量制造。在加入Check-Cap之前，Belkar先生担任美敦力公司（Medtronic plc）最近收购的Mazor RoboticsLtd.公司的运营和全球服务Vice President。在加入Mazor Robotics之前，Belkar先生曾在美敦力公司担任过各种执行职务，包括运营总监、制造和运营Vice President以及生产总监。加入Medtronic plc.之前，Belkar先生担任Elscint Medical Systems Ltd.的生产部经理。Belkar先生拥有以色列开放大学（the Open University，Israel）的社会科学BD学位，以及以色列巴伊兰大学（Bar-Ilan University）的物流管理硕士学位和执行工商管理硕士学位。
Joshua Belkar has served as Vice President of Operation since June 2019. Mr. Belkar has more than 20 years of experience managing operations at global medical device companies, including managing large volume manufacturing of capsule-based products. Prior to joining Check-Cap, Mr. Belkar served as vice president of operations and global services at Mazor Robotics Ltd., which was recently acquired by Medtronic Plc. Prior to Mazor Robotics, Mr. Belkar served in various executive roles at Medtronic, including director of operations, vice president of manufacturing and operations and director of production. Before joining Medtronic Plc., Mr. Belkar served as manager of production at Elscint Medical Systems Ltd. Mr. Belkar holds a BD degree in Social Sciences from the Open University, Israel, and an MA degree in logistic management and an executive MBA degree, both from Bar-Ilan University, Israel.- Joshua Belkar自2019年6月起担任运营Vice President。Belkar先生拥有超过20年的在全球医疗器械公司管理运营的经验，包括管理基于胶囊的产品的大批量制造。在加入Check-Cap之前，Belkar先生担任美敦力公司（Medtronic plc）最近收购的Mazor RoboticsLtd.公司的运营和全球服务Vice President。在加入Mazor Robotics之前，Belkar先生曾在美敦力公司担任过各种执行职务，包括运营总监、制造和运营Vice President以及生产总监。加入Medtronic plc.之前，Belkar先生担任Elscint Medical Systems Ltd.的生产部经理。Belkar先生拥有以色列开放大学（the Open University，Israel）的社会科学BD学位，以及以色列巴伊兰大学（Bar-Ilan University）的物流管理硕士学位和执行工商管理硕士学位。
- Joshua Belkar has served as Vice President of Operation since June 2019. Mr. Belkar has more than 20 years of experience managing operations at global medical device companies, including managing large volume manufacturing of capsule-based products. Prior to joining Check-Cap, Mr. Belkar served as vice president of operations and global services at Mazor Robotics Ltd., which was recently acquired by Medtronic Plc. Prior to Mazor Robotics, Mr. Belkar served in various executive roles at Medtronic, including director of operations, vice president of manufacturing and operations and director of production. Before joining Medtronic Plc., Mr. Belkar served as manager of production at Elscint Medical Systems Ltd. Mr. Belkar holds a BD degree in Social Sciences from the Open University, Israel, and an MA degree in logistic management and an executive MBA degree, both from Bar-Ilan University, Israel.
- Doron Tavlin
Doron Tavlin自2017年以来一直担任我们的Vice President，业务发展。2016年至2017年，塔夫林先生曾与美敦力风险投资公司和企业开发团队合作。2014年至2016年，Tavlin先生担任BlueWind Medical的首席运营官，并于2010年至2014年担任Rainbow Medical的执行Vice President。Tavlin先生在纽约大学斯特恩商学院（New York University Stern School of Business）获得工商管理硕士学位，并在纽约城市大学（City University of New York）获得电气工程学士学位。
Doron Tavlin has been serving as our Vice President, Business Development since 2017. From 2016 to 2017 Mr. Tavlin worked with the Medtronic Ventures and Corporate Development team. From 2014 to 2016 Mr. Tavlin served as Chief Operating Officer of BlueWind Medical, and from 2010 to 2014 as Executive Vice President at Rainbow Medical. Mr. Tavlin received his M.B.A. from New York University Stern School of Business and his B.S.E.E. in Electrical Engineering from City University of New York.- Doron Tavlin自2017年以来一直担任我们的Vice President，业务发展。2016年至2017年，塔夫林先生曾与美敦力风险投资公司和企业开发团队合作。2014年至2016年，Tavlin先生担任BlueWind Medical的首席运营官，并于2010年至2014年担任Rainbow Medical的执行Vice President。Tavlin先生在纽约大学斯特恩商学院（New York University Stern School of Business）获得工商管理硕士学位，并在纽约城市大学（City University of New York）获得电气工程学士学位。
- Doron Tavlin has been serving as our Vice President, Business Development since 2017. From 2016 to 2017 Mr. Tavlin worked with the Medtronic Ventures and Corporate Development team. From 2014 to 2016 Mr. Tavlin served as Chief Operating Officer of BlueWind Medical, and from 2010 to 2014 as Executive Vice President at Rainbow Medical. Mr. Tavlin received his M.B.A. from New York University Stern School of Business and his B.S.E.E. in Electrical Engineering from City University of New York.
- Oren Zarchin
Oren Zarchin自2017年以来一直担任我们的Vice President，产品开发。Zarchin博士曾于2011年至2017年担任Philips梦百合的董事，领导计算机断层摄影业务的多学科研发团队和产品平台。Zarchin博士从2008年到2011年担任El-Mul Technologies的研发主管。Zarchin博士拥有魏茨曼科学研究所（Weizmann Institute of Science，M.SC.）物理学博士学位。物理学优等生和理学学士学位。特拉维夫大学计算机科学和物理学优等生。
Oren Zarchin has been serving as our Vice President, Product Development since 2017. Dr. Zarchin served as Director at Philips Healthcare from 2011 to 2017 leading multi-disciplinary R&D teams and product platforms for the Computed Tomography business. Dr. Zarchin served as the Head of R&D at El-Mul Technologies from 2008 to 2011. Dr. Zarchin has a Ph.D. in Physics from the Weizmann institute of Science, M.Sc. summa cum laude in Physics and B.Sc. cum laude in Computer Science and Physics from Tel-Aviv University.- Oren Zarchin自2017年以来一直担任我们的Vice President，产品开发。Zarchin博士曾于2011年至2017年担任Philips梦百合的董事，领导计算机断层摄影业务的多学科研发团队和产品平台。Zarchin博士从2008年到2011年担任El-Mul Technologies的研发主管。Zarchin博士拥有魏茨曼科学研究所（Weizmann Institute of Science，M.SC.）物理学博士学位。物理学优等生和理学学士学位。特拉维夫大学计算机科学和物理学优等生。
- Oren Zarchin has been serving as our Vice President, Product Development since 2017. Dr. Zarchin served as Director at Philips Healthcare from 2011 to 2017 leading multi-disciplinary R&D teams and product platforms for the Computed Tomography business. Dr. Zarchin served as the Head of R&D at El-Mul Technologies from 2008 to 2011. Dr. Zarchin has a Ph.D. in Physics from the Weizmann institute of Science, M.Sc. summa cum laude in Physics and B.Sc. cum laude in Computer Science and Physics from Tel-Aviv University.
- Ori Hadomi
Ori Hadomi，从2003年1月起担任我们公司的首席执行官和董事会成员。在加入我们公司之前，他在Image Navigation（原DenX Medical Software Systems）担任首席财务官及业务发展副总裁。他在耶路撒冷的Hebrew University获得了化学学士学位及经济学辅修学位，以及工业化学与工商管理硕士学位。
Ori Hadomi has been serving as our Chief Executive Officer and a member of our board of directors since January 2003. Prior to joining us, Mr. Hadomi served as the chief financial officer and vice president of business development of Image Navigation Ltd. formerly known as DenX Medical Software Systems Ltd.. Mr. Hadomi holds a B.A. in chemistry with a minor in economics, as well as a M.Sc. in industrial chemistry and business administration from the Hebrew University, Jerusalem.- Ori Hadomi，从2003年1月起担任我们公司的首席执行官和董事会成员。在加入我们公司之前，他在Image Navigation（原DenX Medical Software Systems）担任首席财务官及业务发展副总裁。他在耶路撒冷的Hebrew University获得了化学学士学位及经济学辅修学位，以及工业化学与工商管理硕士学位。
- Ori Hadomi has been serving as our Chief Executive Officer and a member of our board of directors since January 2003. Prior to joining us, Mr. Hadomi served as the chief financial officer and vice president of business development of Image Navigation Ltd. formerly known as DenX Medical Software Systems Ltd.. Mr. Hadomi holds a B.A. in chemistry with a minor in economics, as well as a M.Sc. in industrial chemistry and business administration from the Hebrew University, Jerusalem.
- Sharon Levita
Sharon Levita，从2008年2月起担任公司的首席财务官。在加入Mazor之前，她于1999年至2008年在Lumenis Ltd.（一家医疗激光和光技术公司）担任多种职位，包括业务发展总监、财务执行副总裁和财务总监。她持有Bar-Ilan University的工商管理硕士学位（金融方向），还从Haifa University。获得了经济与会计的学士学位。她还是一名注册会计师。
Sharon Levita has been serving as our Chief Financial Officer and Corporate Secretary since February 2008 and as our Vice President, Business Operations since June 2017. Prior to joining Mazor, from 1999 to 2008 Mrs. Levita held various senior positions at Lumenis Ltd. Nasdaq: LMNS, a medical lasers and light-based technology company, including Director of Business Development, Executive Vice President of Finance, and Corporate Controller. She holds an M.A. in Business Administration, specializing in finance from Bar-Ilan University, and received her B.A. in Economics and Accounting from Haifa University. Mrs. Levita is a certified public accountant.- Sharon Levita，从2008年2月起担任公司的首席财务官。在加入Mazor之前，她于1999年至2008年在Lumenis Ltd.（一家医疗激光和光技术公司）担任多种职位，包括业务发展总监、财务执行副总裁和财务总监。她持有Bar-Ilan University的工商管理硕士学位（金融方向），还从Haifa University。获得了经济与会计的学士学位。她还是一名注册会计师。
- Sharon Levita has been serving as our Chief Financial Officer and Corporate Secretary since February 2008 and as our Vice President, Business Operations since June 2017. Prior to joining Mazor, from 1999 to 2008 Mrs. Levita held various senior positions at Lumenis Ltd. Nasdaq: LMNS, a medical lasers and light-based technology company, including Director of Business Development, Executive Vice President of Finance, and Corporate Controller. She holds an M.A. in Business Administration, specializing in finance from Bar-Ilan University, and received her B.A. in Economics and Accounting from Haifa University. Mrs. Levita is a certified public accountant.
- Moshe Shoham
Moshe Shoham，是我们的联合创始人之一，从2003年起担任首席技术官。从2001年至2011年，他是我们公司董事。从2005年至2010年，他担任Technion-Israel Institute of Technology的制造系统与技术中心负责人。从1990年起，他一直担任Technion的教员。从2005年起，他在Technion的机械工程部门担任首席教授，同时还在Microbot Medical担任董事。他持有Technion的航空工程学士学位，机械工程硕士与博士学位。
Moshe Shoham, one of our co-founders, has been serving as our Chief Technology Officer since 2003. From 2001 to 2011 Professor Shoham served as one of our directors. From 2005 to 2010 Professor Shoham served as the Head of the Center for Manufacturing Systems and Robotics of the Technion-Israel Institute of Technology, or Technion. Since 1990 Professor Shoham has been serving as a faculty member of the Technion, and since 2005 as an endowed Chaired Professor at the Department of Mechanical Engineering of the Technion. Professor Shoham also serves as a director at Diagnostics Robotics Ltd. since 2017 and from 2012 to 2017 Professor Shoham served as a director at Microbot Medical Ltd. Professor Shoham holds a B.Sc. degree in Aeronautical Engineering, an M.Sc. degree and a Ph.D. in Mechanical Engineering, all degrees from the Technion. Mr. Shoham is also a Foreign Member of the U.S. National Academy of Engineering.- Moshe Shoham，是我们的联合创始人之一，从2003年起担任首席技术官。从2001年至2011年，他是我们公司董事。从2005年至2010年，他担任Technion-Israel Institute of Technology的制造系统与技术中心负责人。从1990年起，他一直担任Technion的教员。从2005年起，他在Technion的机械工程部门担任首席教授，同时还在Microbot Medical担任董事。他持有Technion的航空工程学士学位，机械工程硕士与博士学位。
- Moshe Shoham, one of our co-founders, has been serving as our Chief Technology Officer since 2003. From 2001 to 2011 Professor Shoham served as one of our directors. From 2005 to 2010 Professor Shoham served as the Head of the Center for Manufacturing Systems and Robotics of the Technion-Israel Institute of Technology, or Technion. Since 1990 Professor Shoham has been serving as a faculty member of the Technion, and since 2005 as an endowed Chaired Professor at the Department of Mechanical Engineering of the Technion. Professor Shoham also serves as a director at Diagnostics Robotics Ltd. since 2017 and from 2012 to 2017 Professor Shoham served as a director at Microbot Medical Ltd. Professor Shoham holds a B.Sc. degree in Aeronautical Engineering, an M.Sc. degree and a Ph.D. in Mechanical Engineering, all degrees from the Technion. Mr. Shoham is also a Foreign Member of the U.S. National Academy of Engineering.
- Eliyahu Zehavi
Eliyahu Zehavi，他自2001年担任公司首席营运官，负责公司的研发部门和运营。从1998年6月至2001年1月，他担任Elscint的工程副总裁。他在Ben-Gurion University获得了计算机与电气工程学士学位，并在以色列荷兹利亚的Interdisciplinary Center获得了MBA学位。
Eliyahu Zehavi has been serving as our Executive Vice President, Advanced Technologies, responsible for developing and integrating the various elements that comprise Mazor’s products. He previously served as our Chief Operation Officer and Vice President of Research and Development from 2001 to 2017. From June 1998 to January 2001 Mr. Zehavi served as the vice president of engineering of Elscint, Ltd. Mr. Zehavi holds a B.Sc. in Computer and Electrical Engineering from Ben-Gurion University, and an M.B.A. from the Interdisciplinary Center, Herzliya, Israel.- Eliyahu Zehavi，他自2001年担任公司首席营运官，负责公司的研发部门和运营。从1998年6月至2001年1月，他担任Elscint的工程副总裁。他在Ben-Gurion University获得了计算机与电气工程学士学位，并在以色列荷兹利亚的Interdisciplinary Center获得了MBA学位。
- Eliyahu Zehavi has been serving as our Executive Vice President, Advanced Technologies, responsible for developing and integrating the various elements that comprise Mazor’s products. He previously served as our Chief Operation Officer and Vice President of Research and Development from 2001 to 2017. From June 1998 to January 2001 Mr. Zehavi served as the vice president of engineering of Elscint, Ltd. Mr. Zehavi holds a B.Sc. in Computer and Electrical Engineering from Ben-Gurion University, and an M.B.A. from the Interdisciplinary Center, Herzliya, Israel.
- Doron Dinstein
Doron Dinstein，他自2012年12月担任首席医疗官。从2009年至2012年，他担任公司副总裁，负责市场营销和业务发展。2004年至2009年，他在Itamar Medical（一家以色列上市公司）担任心血管应用主管。他获得了Northwestern University和Tel Aviv University联合颁发的工商管理硕士学位。他在Tel-Aviv University School of Medicine获得了医学硕士学位和医学博士学位。
Doron Dinstein has been serving as our Chief Medical Officer since December 2012. From 2009 to 2012 Dr. Dinstein served as our Vice President of Marketing and Business Development. From 2004 to 2009 Dr. Dinstein served as the Manager of Cardiovascular Applications at Itamar Medical, Ltd., an Israeli public company. Dr. Dinstein holds a joint Executive M.B.A degree from Northwestern University and Tel Aviv University. Dr. Dinstein received a B.M.Sc. and an M.D. from Tel-Aviv University School of Medicine.- Doron Dinstein，他自2012年12月担任首席医疗官。从2009年至2012年，他担任公司副总裁，负责市场营销和业务发展。2004年至2009年，他在Itamar Medical（一家以色列上市公司）担任心血管应用主管。他获得了Northwestern University和Tel Aviv University联合颁发的工商管理硕士学位。他在Tel-Aviv University School of Medicine获得了医学硕士学位和医学博士学位。
- Doron Dinstein has been serving as our Chief Medical Officer since December 2012. From 2009 to 2012 Dr. Dinstein served as our Vice President of Marketing and Business Development. From 2004 to 2009 Dr. Dinstein served as the Manager of Cardiovascular Applications at Itamar Medical, Ltd., an Israeli public company. Dr. Dinstein holds a joint Executive M.B.A degree from Northwestern University and Tel Aviv University. Dr. Dinstein received a B.M.Sc. and an M.D. from Tel-Aviv University School of Medicine.
- Christopher Prentice
Christopher Prentice，他自2013年9月担任America & Global Marketing的高级副总裁。从2012年7月直到2013年9月，他担任公司的营销副总裁。从2010年到2012年7月，他担任公司在美国东南部地区的销售总监。在加入Mazor之前，他任职于Tampa General Hospital的管理层。他从位于纽约州西点的美国军事学院（United States Military Academy）毕业。他在Western New England University获得了工商管理硕士学位，并在University of South Florida获得了健康管理硕士学位。
Christopher Prentice has served as the Chief Executive Officer of our U.S. Subsidiary, Mazor Robotics Inc., since October 2014 and as the Company’s Commercial Leader, in charge of the Global Sales Team, since July 2016. From September 2013 until October 2014 Mr. Prentice served as our Senior Vice President of America & Global Marketing and as Vice President of Marketing from July 2012 until September 2013. From 2010 to July 2012 Mr. Prentice served as our sales director for the Southeast region in the United States. Prior to joining Mazor, Mr. Prentice held sales, marketing, and finance positions within Johnson & Johnson, Intuitive Surgical, and Tampa General Hospital. Mr. Prentice graduated from the United States Military Academy at West Point, holds an M.B.A degree from Western New England University, and a Master of Health Administration from the University of South Florida.- Christopher Prentice，他自2013年9月担任America & Global Marketing的高级副总裁。从2012年7月直到2013年9月，他担任公司的营销副总裁。从2010年到2012年7月，他担任公司在美国东南部地区的销售总监。在加入Mazor之前，他任职于Tampa General Hospital的管理层。他从位于纽约州西点的美国军事学院（United States Military Academy）毕业。他在Western New England University获得了工商管理硕士学位，并在University of South Florida获得了健康管理硕士学位。
- Christopher Prentice has served as the Chief Executive Officer of our U.S. Subsidiary, Mazor Robotics Inc., since October 2014 and as the Company’s Commercial Leader, in charge of the Global Sales Team, since July 2016. From September 2013 until October 2014 Mr. Prentice served as our Senior Vice President of America & Global Marketing and as Vice President of Marketing from July 2012 until September 2013. From 2010 to July 2012 Mr. Prentice served as our sales director for the Southeast region in the United States. Prior to joining Mazor, Mr. Prentice held sales, marketing, and finance positions within Johnson & Johnson, Intuitive Surgical, and Tampa General Hospital. Mr. Prentice graduated from the United States Military Academy at West Point, holds an M.B.A degree from Western New England University, and a Master of Health Administration from the University of South Florida.